Literature DB >> 15386712

Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database.

Benjamin G Fincke1, Kerri Snyder, Colleen Cantillon, Stephan Gaehde, Peter Standring, Louis Fiore, Mary Brophy, David R Gagnon.   

Abstract

PURPOSE: To develop and compare three operational definitions of polypharmacy using a large prescription database.
METHODS: We defined Cumulative polypharmacy as all prescriptions filled during a 178 day window--which captured 95% of eventual refills as calculated from Kaplan-Meier and cumulative incidence curves. Continuous polypharmacy was all prescriptions filled in two such windows 6 months apart. Simultaneous polypharmacy was the number of prescriptions active on a particular day, as determined by fill dates and amount of medication given. We applied these definitions to the outpatient prescription files of New England veterans and compared the resulting estimates of polypharmacy using descriptive statistics.
RESULTS: 118,013 patients received at least one prescription between January 1998 and July 1999. Cumulative polypharmacy averaged 3.54 (SD = 4.95) medications and continuous polypharmacy averaged 1.96 (SD = 3.23). Examination of simultaneous polypharmacy over 40 2-week intervals revealed an average of 2.63 (CI 2.61-2.65), a minimum of 1.09 (CI 1.08-1.10) and maximum of 4.94 (CI 4.92-4.96). One arbitrarily selected observation point had an average of 3.87 (SD = 3.17).
CONCLUSIONS: Our definitions of cumulative and continuous polypharmacy serve to set upper and lower bounds for the estimate of polypharmacy. Our method for simultaneous polypharmacy gives numbers that diverge in some respects, but it is better at showing transient changes in medications. The methods are complementary and allow exploration of various aspects of medication use, such as cumulative medication exposure over time, the influence of chronic medical problems, and the causes of rapid changes in medications.

Entities:  

Mesh:

Year:  2005        PMID: 15386712     DOI: 10.1002/pds.966

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  26 in total

1.  Prevalence and Geographic Variations of Polypharmacy Among West Virginia Medicaid Beneficiaries.

Authors:  Xue Feng; Xi Tan; Brittany Riley; Tianyu Zheng; Thomas K Bias; James B Becker; Usha Sambamoorthi
Journal:  Ann Pharmacother       Date:  2017-06-21       Impact factor: 3.154

2.  Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

Authors:  Cynthia A Fontanella; Lynn A Warner; Gary S Phillips; Jeffrey A Bridge; John V Campo
Journal:  Psychiatr Serv       Date:  2014-10-31       Impact factor: 3.084

3.  Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Authors:  Kirsten K Viktil; Hege S Blix; Tron A Moger; Aasmund Reikvam
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

4.  Polypharmacy and Multimorbidity Among Medicaid Enrollees: A Multistate Analysis.

Authors:  Xue Feng; Xi Tan; Brittany Riley; Tianyu Zheng; Thomas Bias; Usha Sambamoorthi
Journal:  Popul Health Manag       Date:  2017-07-06       Impact factor: 2.459

5.  Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Massimo Cartabia; Paolo Risso; Daniela Mari; Mauro Tettamanti; Alberto Parabiaghi; Luca Pasina; Codjo Djignefa Djade; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-28       Impact factor: 2.953

6.  Polypharmacy and Renal Failure in Nursing Home Residents: Results of the Inappropriate Medication in Patients with Renal Insufficiency in Nursing Homes (IMREN) Study.

Authors:  Michael Dörks; Stefan Herget-Rosenthal; Guido Schmiemann; Falk Hoffmann
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

7.  Concomitant use of two or more antipsychotic drugs is common in Sweden.

Authors:  Annica Bergendal; Helena Schiöler; Björn Wettermark; Karin Sparring Björkstén
Journal:  Ther Adv Psychopharmacol       Date:  2015-08

8.  Frequency and Predictors of Polypharmacy in US Medicare Patients: A Cross-Sectional Analysis at the Patient and Physician Levels.

Authors:  Michael I Ellenbogen; Peiqi Wang; Heidi N Overton; Christine Fahim; Angela Park; William E Bruhn; Jennifer L Carnahan; Amy M Linsky; Seki A Balogun; Martin A Makary
Journal:  Drugs Aging       Date:  2020-01       Impact factor: 3.923

9.  Predictors of primary non-adherence to concomitant chronic treatment in HIV-infected patients with antiretroviral therapy.

Authors:  Yolanda Borrego; Encarnación Gómez-Fernández; Rocío Jiménez; Rosa Cantudo; Carmen V Almeida-González; Ramón Morillo
Journal:  Eur J Hosp Pharm       Date:  2017-02-23

10.  Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.

Authors:  Bo Hovstadius; Bengt Astrand; Göran Petersson
Journal:  BMC Clin Pharmacol       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.